Javascript must be enabled to continue!
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
View through CrossRef
Background: Ginger has long been used as an antiemetic herb in various systems for traditional medicine. However, lack of data on its utility in preventing chemotherapy induced vomiting prevents us from reaching any definite statement. Objectives: To determine the effect of prophylactic use of ginger in decreasing the delayed chemotherapy induced vomiting, when added as an add on therapy to the standard antiemetic treatment in patients receiving highly emetogenic chemotherapy. Study Design: Randomized control trial. Setting: Department of Medical Oncology, Jinnah Hospital Lahore. Period: July 2014 and January 2016. Materials and Methods: A total of 90 patients were selected and randomly allocated into two groups, A and B, having 45 patients each. Patients in both groups received highly emetogenic chemotherapy regimens. For prophylaxis of CINV, Group A received olanzapine based standard antiemetic regimen and cap ginger 500 mg per oral TID 3 days prior to chemotherapy and 3 days after chemotherapy and Group B received olanzapine based standard antiemetic regimen only. Observation for frequency and grade of delayed chemotherapy induced vomiting in all cases was done at day 8 of chemotherapy. Results: The mean age of the patients in group A (intervention group) is 44.5±12.8 years and that in group B (standard group) is 41.4±13.9 years. 29 (64.4%) patients in the intervention group had no vomiting at all as compared to the 19(42.2%) patients in standard group. Mild/Grade 1 vomiting was experienced in 6 (13.3%) patients in the intervention group as compared to 9 (20.0%) patients in the standard arm. There was also a significant reduction in moderate/grade 2 vomiting in intervention arm 7 patients (15.5%) as compared to 11 patients ( 24.4%) in control arm. There was also significant reduction in the severe vomiting that is grade 3 and 4 in group A with the use of ginger capsulesas grade 3 vomiting was observed in only 6.6%versus 15.5% ptients, while none had grade 4 vomiting in group A compared to one patient (2.2%) in group B. Conclusion: Significant decrease in delayed chemotherapy induced vomiting was achieved in patients who were treated with standard antiemetic regimen plus ginger than those treated with standard antiemetic regimen alone, in patients receiving highly emetogenic chemotherapy. So the addition of ginger to standard antiemetic regimens is a safe, less expensive and effective additional treatment option.
Independent Medical Trust
Title: CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
Description:
Background: Ginger has long been used as an antiemetic herb in various systems for traditional medicine.
However, lack of data on its utility in preventing chemotherapy induced vomiting prevents us from reaching any definite statement.
Objectives: To determine the effect of prophylactic use of ginger in decreasing the delayed chemotherapy induced vomiting, when added as an add on therapy to the standard antiemetic treatment in patients receiving highly emetogenic chemotherapy.
Study Design: Randomized control trial.
Setting: Department of Medical Oncology, Jinnah Hospital Lahore.
Period: July 2014 and January 2016.
Materials and Methods: A total of 90 patients were selected and randomly allocated into two groups, A and B, having 45 patients each.
Patients in both groups received highly emetogenic chemotherapy regimens.
For prophylaxis of CINV, Group A received olanzapine based standard antiemetic regimen and cap ginger 500 mg per oral TID 3 days prior to chemotherapy and 3 days after chemotherapy and Group B received olanzapine based standard antiemetic regimen only.
Observation for frequency and grade of delayed chemotherapy induced vomiting in all cases was done at day 8 of chemotherapy.
Results: The mean age of the patients in group A (intervention group) is 44.
5±12.
8 years and that in group B (standard group) is 41.
4±13.
9 years.
29 (64.
4%) patients in the intervention group had no vomiting at all as compared to the 19(42.
2%) patients in standard group.
Mild/Grade 1 vomiting was experienced in 6 (13.
3%) patients in the intervention group as compared to 9 (20.
0%) patients in the standard arm.
There was also a significant reduction in moderate/grade 2 vomiting in intervention arm 7 patients (15.
5%) as compared to 11 patients ( 24.
4%) in control arm.
There was also significant reduction in the severe vomiting that is grade 3 and 4 in group A with the use of ginger capsulesas grade 3 vomiting was observed in only 6.
6%versus 15.
5% ptients, while none had grade 4 vomiting in group A compared to one patient (2.
2%) in group B.
Conclusion: Significant decrease in delayed chemotherapy induced vomiting was achieved in patients who were treated with standard antiemetic regimen plus ginger than those treated with standard antiemetic regimen alone, in patients receiving highly emetogenic chemotherapy.
So the addition of ginger to standard antiemetic regimens is a safe, less expensive and effective additional treatment option.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Pengaruh Aromaterapi Lemon Terhadap Pengurangan Mual Muntah Pada Ibu Hamil Trimester I Di Klinik Hj.Dermawati
Pengaruh Aromaterapi Lemon Terhadap Pengurangan Mual Muntah Pada Ibu Hamil Trimester I Di Klinik Hj.Dermawati
During the first trimester of pregnancy, nausea and vomiting are frequently experienced. Vomiting and nausea are most common in the morning, yet can happen at any time of day or ni...
Clinical Predictors of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Doxorubicin and Cyclophosphamide
Clinical Predictors of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Doxorubicin and Cyclophosphamide
Background: Patients with breast cancer often receive emetogenic anthracycline–based chemotherapy as part of their treatment. Chemotherapy-induced nausea and vomiting (CINV) has be...
Pengaruh Terapi Akupresur Terhadap Mual Muntah Pada Pasien Kanker Payudara Yang Menjalani Kemoterapi Di Rsup Dr. M. Djamil Padang
Pengaruh Terapi Akupresur Terhadap Mual Muntah Pada Pasien Kanker Payudara Yang Menjalani Kemoterapi Di Rsup Dr. M. Djamil Padang
Breast cancer is a condition in which cells lose their normal control so that it can result in abnormally rapid and uncontrolled tissue growth. Nausea and vomiting are one of the s...
Reduction of Postoperative Nausea and Vomiting with Spinal Anesthesia: Using Complementary Therapy Peppermint and Lavender Aromatherapy
Reduction of Postoperative Nausea and Vomiting with Spinal Anesthesia: Using Complementary Therapy Peppermint and Lavender Aromatherapy
Nausea and vomiting are common occurrences after surgery with spinal anesthesia, which can lead to complications and delay recovery. Hypotension associated with spinal, epidural, a...
Renal Ewing Sarcoma: A Case Report and Literature Review
Renal Ewing Sarcoma: A Case Report and Literature Review
Abstract
Introduction
Primary renal Ewing sarcoma is an extremely rare and aggressive tumor, representing less than 1% of all renal tumors. This case report contributes valuable in...
Jianpi Yiwei Granules for Chemotherapy-Induced Gastrointestinal Reactions: A Randomized Double-Blind Placebo-Controlled Trial
Jianpi Yiwei Granules for Chemotherapy-Induced Gastrointestinal Reactions: A Randomized Double-Blind Placebo-Controlled Trial
Introduction:
Chemotherapy-induced gastrointestinal reactions are common in non-small cell lung
cancer (NSCLC) patients undergoing carboplatin-based chemotherapy. Jianpi Yiwei gran...

